Welcome to the international HTA database

Showing [24040 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Eftrenonacog alfa - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2016	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Idebenone (Raxone) for Duchenne muscular dystrophy – first line
2016	HAYES, Inc.	MammaPrint 70-Gene breast cancer recurrence assay (Agendia)
2016	HAYES, Inc.	High-frequency left repetitive transcranial magnetic stimulation for treatment-resistant major depressive disorder
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Necitumumab (lung cancer) - Addendum to Commission A16-17]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Microwave tissue ablation for primary and secondary liver cancer
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Ibrutinib (Imbruvica) for relapsed and refractory marginal zone lymphoma – second or subsequent line
2016	HAYES, Inc.	Molecular intelligence (Caris Life Sciences)
2016	HAYES, Inc.	Intravenous immunoglobulin for the treatment of myasthenia gravis
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ticagrelor (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Binimetinib for recurrent or persistent ovarian, fallopian tube or primary peritoneal cancer ─ second and subsequent line
2016	HAYES, Inc.	VeriStrat
2016	HAYES, Inc.	Negative pressure wound therapy for chronic wounds: home use
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Idelalisib (chronic lymphocytic leukaemia) - Addendum to Commission A16-18]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Pexiganan (Locilex) for mild foot infection in diabetic foot ulcers
2016	HAYES, Inc.	Catalys Precision Laser System (OptiMedica Corp.; Abbott Medical Optics) for cataract surgery
2016	HAYES, Inc.	Nitric oxide breath analysis for the diagnosis of asthma
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Elotuzumab - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Subcutaneous tocilizumab for juvenile idiopathic polyarthritis – second line
2016	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Safety and efficacy of antibody-coated stent for the treatment of de novo coronary artery disease]
2016	HAYES, Inc.	Coflex Interlaminar Stabilization Device (Paradigm Spine LLC) for treatment of lumbar spinal stenosis
2016	HAYES, Inc.	Percutaneous radiofrequency ablation for cervical and thoracic spinal indications
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Eribulin (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	HAYES, Inc.	EX-PRESS Glaucoma Filtration Device (Alcon Inc.) for treatment of open-angle glaucoma
2016	HAYES, Inc.	Radial extracorporeal shock wave therapy for chronic plantar fasciitis
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Daratumumab - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Nucleolysis percutaneous laser disc decompression]
2016	HAYES, Inc.	Iluvien (Fluocinolone Acetonide Intravitreal Implant; Alimera Sciences) for treatment of diabetic macular edema
2016	HAYES, Inc.	Radiofrequency ablation for facet joint denervation for chronic low back pain
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Migalastat - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2016	HAYES, Inc.	Infliximab (Remicade; Janssen Biotech Inc.) for first-line treatment of pediatric Crohn disease
2016	HAYES, Inc.	Sofosbuvir-velpatasvir for chronic HCV infection
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ataluren - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	HAYES, Inc.	MarginProbe System (Dune Medical Devices) for intraoperative assessment of surgical margins in patients with breast cancer
2016	HAYES, Inc.	Absorbable perirectal spacer (SpaceOAR System; Augmenix Inc.) during radiation therapy forprostate cancer
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Talimogene laherparepvec - Benefit assessment according to §35a Social Code Book V]
2016	HAYES, Inc.	Noncontact low-frequency ultrasound using the MIST Therapy System (Celleration Inc.) for treatment of lower extremity arterial and diabetic foot ulcers
2016	HAYES, Inc.	DeNovo NT natural tissue graft (Zimmer Inc.) for articular cartilage repair
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nivolumab (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease
2016	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation and approach to fibromyalgia: update of scientific evidence]
2016	HAYES, Inc.	Noncontact low-frequency ultrasound using the MIST Therapy System (Celleration Inc.) for treatment of venous leg ulcers
2016	HAYES, Inc.	Dexamethasone intravitreal implant (Ozurdex; Allergan Inc.) for treatment of diabetic macular edema
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Selexipag - Benefit assessment according to §35a Social Code Book V]
2016	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation and approach to chronic fatigue syndrome: update of scientific evidence]
2016	HAYES, Inc.	PleurX peritoneal catheter for home management of malignant ascites
2016	HAYES, Inc.	First-Line treatment of non-Hodgkin lymphoma with bendamustine in combination with anti-cd20 antibodies
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Obinutuzumab - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	HAYES, Inc.	Polidocanol endovenous microfoam (Varithena) 1% for treatment of varicose veins
2016	HAYES, Inc.	Hysteroscopic morcellation for treatment of uterine submucosal fibroids and endometrial polyps
2016	HAYES, Inc.	Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of chronic pain related to cancer or cancer treatment
2016	HAYES, Inc.	iFuse implant system (SI-Bone Inc.) for sacroiliac joint fusion for treatment of low back pain
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[UV crosslinking with riboflavin in keratoconus]
2016	HAYES, Inc.	Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of pain not related to cancer
2016	HAYES, Inc.	Kiva VCF treatment system for treatment of vertebral compression fractures
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Aromatase inhibitors in female breast cancer]
2016	NIHR Health Technology Assessment programme	Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records
2016	HAYES, Inc.	Sebelipase Alfa (Kanuma) for treatment of lysosomal acid lipase deficiency
2016	HAYES, Inc.	Laparoscopic radiofrequency volumetric thermal ablation (Acessa System; Halt Medical Inc.) for treatment of uterine fibroids
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nivolumab (renal cell carcinoma) - Addendum to Commission A16-24]
2016	Technology Assessment at SickKids (TASK)	Will the growth spurt continue? Trends in child health. Economic evaluation: 1980 to 2013
2016	HAYES, Inc.	Speech therapy for treatment of adults with primary progressive aphasia
2016	HAYES, Inc.	Lumen-apposing metal stents (Axios Stent and Delivery System; Boston Scientific.) for management of pancreatic pseudocysts and walled-off necrosis
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Shared governance for nursing assistants and other ancillary medical staff in the hospital setting
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nivolumab (NSCLC) - Addendum to Commission A16-25]
2016	NIHR Health Technology Assessment programme	Enhanced invitation methods and uptake of health checks in primary care: randomised controlled trial and cohort study using electronic health records
2016	NIHR Health Services and Delivery Research programme	How can frontline expertise and new models of care best contribute to safely reducing avoidable acute admissions? A mixed-methods study of four acute hospitals
2016	NIHR Health Technology Assessment programme	Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model
2016	HAYES, Inc.	Negative pressure wound therapy with instillation
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Frequency of vital sign measurement
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib (new therapeutic indication) - Benefit assessment according to §35a SGB V]
2016	NIHR Health Services and Delivery Research programme	Effective board governance of safe care: a (theoretically underpinned) cross-sectioned examination of the breadth and depth of relationships through national quantitative surveys and in-depth qualitative case studies
2016	NIHR Health Technology Assessment programme	A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study
2016	HAYES, Inc.	Ovarian tissue cryopreservation for preservation of fertility in patients undergoing gonadotoxic cancer treatment
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Amiodarone for prevention of atrial fibrillation in cardiac surgery patients
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ibrutinib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2016	NIHR Health Services and Delivery Research programme	The use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial with embedded feasibility study
2016	HAYES, Inc.	Peristeen anal irrigation system (Coloplast) for bowel management in pediatric populations
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Nurse to nurse communication: bedside change of shift report
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Saxagliptin - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Microwave tissue ablation of primary and secondary lung cancer
2016	HAYES, Inc.	Bronchial thermoplasty for treatment of asthma
2016	HAYES, Inc.	Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Overview of hyperbaric oxygen therapy
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Saxagliptin/metformin - Benefit assessment according to §35a Social Code Book V]
2016	HAYES, Inc.	Comparative effectiveness of allogeneic hematopoietic stem cell transplant versus drug-based strategies for treatment of chronic myelogenous leukemia
2016	HAYES, Inc.	Stereotactic body radiation therapy with CyberKnife Robotic Radiosurgery System (Accuray Inc.) boost treatment in primary localized prostate cancer
2016	Penn Medicine Center for Evidence-based Practice (CEP)	An updated review of disinfecting caps and antimicrobial locks for reducing blood stream infections associated with central venous catheters
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sitagliptin - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Minimally invasive, lumbar decompression and dynamic using an interlaminar device, with no rigid fixation to the vertebral pedicles, implantation between the spinous processes of one or two lumbar motion segments
2016	National Institute for Health and Care Excellence (NICE)	Extracorporeal shockwave therapy for Achilles tendinopathy. NICE interventional procedures guidance 571
2016	HAYES, Inc.	Comparative effectiveness of bioresorbable vascular scaffold stents versus other drug-eluting stents for the treatment of coronary artery disease
2016	HAYES, Inc.	Stereotactic body radiation therapy with CyberKnife Robotic Radiosurgery System (Accuray Inc.) monotherapy of primary localized prostate cancer
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Disease trends and hospital utilizations projections
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sitagliptin/metformin - Benefit assessment according to §35a Social Code Book V]
2016	National Institute for Health and Care Excellence (NICE)	Radiation therapy for early Dupuytren's disease. NICE interventional procedures guidance 573
2016	HAYES, Inc.	Comparative effectiveness of cryoablation and radiofrequency ablation for atrial fibrillation